Abstract:Post-translational and epigenetic regulation are important mechanisms controlling functions of genes and proteins. Although the "classic" estrogen receptors (ERs) have been acknowledged to function in mediating estrogen effects via transcriptional mechanisms, estrogenic agents modulate the turnover of several proteins via post-transcriptional and post-translational pathways including epigenetics. For instance, the metabolic and angiogenic action of G-protein coupled estrogen receptor (GPER) in vascular endothelial cells has been recently elucidated. By interacting with GPER, 17<i>β</i>-estradiol and the GPER agonist G1 enhance endothelial stability of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) and capillary tube formation by increasing ubiquitin-specific peptidase 19 levels, thereby reducing PFKFB3 ubiquitination and proteasomal degradation. In addition to ligands, the functional expression and trafficking of ERs can be modulated by post-translational modification, including palmitoylation. MicroRNAs (miRNAs), the most abundant form of endogenous small RNAs in humans, regulate multiple target genes and are at the center of the multi-target regulatory network. This review also discusses the emerging evidence of how miRNAs affect glycolytic metabolism in cancer, as well as their regulation by estrogens. Restoring dysregulated miRNA expression represents a promising strategy to counteract the progression of cancer and other disease conditions. Accordingly, estrogen post-transcriptional regulatory and epigenetic mechanisms represent novel targets for pharmacological and nonpharmacological intervention for the treatment and prevention of hormone-sensitive noncommunicable diseases, including estrogen-sensitive cancers of the reproductive system in women. SIGNIFICANCE STATEMENT: The effects of estrogen are mediated by several mechanisms that are not limited to the transcriptional regulation of target genes. Slowing down the turnover of master regulators of metabolism by estrogens allows cells to rapidly adapt to environmental cues. Identification of estrogen-targeted microRNAs may lead to the development of novel RNA therapeutics that disrupt pathological angiogenesis in estrogen-dependent cancers.

Research Advancement of Estrogen and Energy Metabolism of Glucose

The Central Mechanism for Estrogen Receptor to Mediate Nutrients and Energy Metabolism

Estrogen deficiency exacerbates learning and memory deficits associated with glucose metabolism disorder in APP/PS1 double transgenic female mice

Aberrant Energy Metabolism in Alzheimer’s Disease

Research progress of relationship between estrogen and cognition in women

Aberrant Energy Metabolism in Alzheimer's Disease

[Effects of Estrogen in the Central Nervous System].

Glucose Metabolism, Neural Cell Senescence and Alzheimer's Disease

Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease.

Role of Estrogen and Its Receptors in Adipose Tissue Glucose Metabolism in Pre- and Postmenopausal Women

Dysregulation of energy metabolism in Alzheimer's disease

Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1

The role of estrogen in Alzheimer's disease pathogenesis and therapeutic potential in women

Regulation of mitochondrial dysfunction by estrogens and estrogen receptors in Alzheimer's disease: A focused review

The role of estrogen in Alzheimer’s disease pathogenesis and therapeutic potential in women

Estrogen and Glycemic Homeostasis: The Fundamental Role of Nuclear Estrogen Receptors ESR1/ESR2 in Glucose Transporter GLUT4 Regulation

Glucose Metabolic Abnormality: A Crosstalk between Depression and Alzheimer's Disease

Advancements in the study of glucose metabolism in relation to tumor progression and treatment

Post-transcriptional and epigenetic regulation of estrogen signaling

The effect of estrogen therapy on cerebral metabolism in diabetic female rats

Is the beta estradiol receptor receiving enough attention for its metabolic importance in postmenopause?